Challenges and Expert Monitoring in Liposomal Amphotericin-B BE Studies Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin… Continue reading Optimizing Liposomal Amphotericin-B BE Studies